Dr. LeBlanc Discusses End-of-Life Care for Hematologic Malignancies

October 26, 2017
Thomas W. LeBlanc, MD

Thomas W. LeBlanc, MD, MA, medical oncologist, palliative care physician, Duke Cancer Institute, discusses end-of-life care for patients with hematologic malignancies.

Thomas W. LeBlanc, MD, MA, medical oncologist, palliative care physician, Duke Cancer Institute, discusses end-of-life care for patients with hematologic malignancies.

Currently, the quality outcome measures for palliative and end-of-life care focus more on end-of-life than upstream palliative care.

Outcomes for patients with hematologic malignancies appear to be worse across the board when managed by these measures compared with patients with solid tumors, says LeBlanc.


x